1. Home
  2. SNY vs PHLT Comparison

SNY vs PHLT Comparison

Compare SNY & PHLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • PHLT
  • Stock Information
  • Founded
  • SNY 1994
  • PHLT 1976
  • Country
  • SNY France
  • PHLT United States
  • Employees
  • SNY N/A
  • PHLT N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • PHLT Other Consumer Services
  • Sector
  • SNY Health Care
  • PHLT Consumer Discretionary
  • Exchange
  • SNY Nasdaq
  • PHLT Nasdaq
  • Market Cap
  • SNY 113.4B
  • PHLT 601.2M
  • IPO Year
  • SNY N/A
  • PHLT N/A
  • Fundamental
  • Price
  • SNY $47.60
  • PHLT $7.70
  • Analyst Decision
  • SNY Buy
  • PHLT Buy
  • Analyst Count
  • SNY 4
  • PHLT 2
  • Target Price
  • SNY $61.50
  • PHLT $7.88
  • AVG Volume (30 Days)
  • SNY 2.7M
  • PHLT 1.2M
  • Earning Date
  • SNY 10-24-2025
  • PHLT 11-05-2025
  • Dividend Yield
  • SNY 3.40%
  • PHLT N/A
  • EPS Growth
  • SNY 118.56
  • PHLT N/A
  • EPS
  • SNY 8.65
  • PHLT N/A
  • Revenue
  • SNY $53,714,621,258.00
  • PHLT $137,357,000.00
  • Revenue This Year
  • SNY $1.53
  • PHLT $12.38
  • Revenue Next Year
  • SNY $7.06
  • PHLT $10.09
  • P/E Ratio
  • SNY $5.43
  • PHLT N/A
  • Revenue Growth
  • SNY 15.65
  • PHLT 15.21
  • 52 Week Low
  • SNY $44.73
  • PHLT $2.17
  • 52 Week High
  • SNY $60.12
  • PHLT $7.74
  • Technical
  • Relative Strength Index (RSI)
  • SNY 46.93
  • PHLT 81.35
  • Support Level
  • SNY $46.50
  • PHLT $7.56
  • Resistance Level
  • SNY $47.69
  • PHLT $7.67
  • Average True Range (ATR)
  • SNY 0.69
  • PHLT 0.03
  • MACD
  • SNY -0.11
  • PHLT -0.10
  • Stochastic Oscillator
  • SNY 47.19
  • PHLT 100.00

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

About PHLT Performant Healthcare Inc. Common Stock

Performant Healthcare Inc provides solutions to payers in the healthcare industry to identify, prevent, and recover waste and improper payments by leveraging technology, analytics, and proprietary data assets.

Share on Social Networks: